95104-44-2 Usage
Uses
Used in Organic Synthesis:
4-Isoxazolecarboxylic acid, 5-(hydroxymethyl)-3-phenyl-, ethyl ester is used as a synthetic intermediate in organic synthesis for the preparation of various chemical compounds. Its unique structural features make it a valuable component in the development of new molecules with potential applications across different industries.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 4-Isoxazolecarboxylic acid, 5-(hydroxymethyl)-3-phenyl-, ethyl ester is used as a synthetic intermediate for the production of pharmaceuticals or other bioactive molecules. Its structural attributes may contribute to the discovery of new drugs with therapeutic potential.
Used in Chemical Research:
4-Isoxazolecarboxylic acid, 5-(hydroxymethyl)-3-phenyl-, ethyl ester is also utilized in chemical research to explore its properties and reactivity, further expanding the understanding of isoxazole-based compounds and their potential applications.
It is crucial to handle and store 4-Isoxazolecarboxylic acid, 5-(hydroxymethyl)-3-phenyl-, ethyl ester with care due to the potential hazards associated with its chemical nature. Proper safety measures should be implemented to ensure the safe use of 4-Isoxazolecarboxylic acid, 5-(hydroxymethyl)-3-phenyl-, ethyl ester in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 95104-44-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,1,0 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 95104-44:
(7*9)+(6*5)+(5*1)+(4*0)+(3*4)+(2*4)+(1*4)=122
122 % 10 = 2
So 95104-44-2 is a valid CAS Registry Number.
95104-44-2Relevant academic research and scientific papers
SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE
-
Paragraph 0633, (2017/04/04)
Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by positive allosteric modulation of the γ-aminobutyric acid B (GABA-B) receptor. Methods for making the compounds are described. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
